INTRAVENOUS METHYLPREDNISOLONE PULSE THERAPY IN MINIMAL CHANGE NEPHROTIC SYNDROME

Australian and New Zealand Journal of Medicine

Volumn 13, Issue 4, 1983, Pages 349-351

  YEUNG, C K ^a   WONG, K L ^a   NG, W L ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

methylprednisolone; Minimal change; nephrotic syndrome

Indexed keywords

METHYLPREDNISOLONE;

ADVERSE DRUG REACTION; CASE REPORT; DRUG THERAPY; GASTRITIS; GASTROINTESTINAL TOXICITY; HUMAN; INTOXICATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY; MINIMAL CHANGE GLOMERULONEPHRITIS; PROTEINURIA; PULSE THERAPY; STOMACH; THERAPY;

ADOLESCENT; ADULT; COMPARATIVE STUDY; FEMALE; HUMAN; INFUSIONS, PARENTERAL; MALE; METHYLPREDNISOLONE; MIDDLE AGE; NEPHROSIS, LIPOID; PREDNISONE;

EID: 0021085069     PISSN: 00048291     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1983.tb04479.x     Document Type: Article

References (13)

1. Nephrotic syndrome
2. The primary nephrotic syndrome of childhood
3. The nephrotic syndrome in adults with ‘minimal change’ glomerular lesions
4. Treatment of acute allograft rejection with high doses of corticosteroids
5. Oral versus intravenous high‐dose steroid treatment of renal allograft rejection
6. Beneficial effects of methylprednisolone “pulse” therapy in diffuse proliferative lupus nephritis
7. High‐dose intravenous methylprednisolone pulse‐therapy in systemic lupus erythematosus
8. Pulse methylprednisolone therapy in diffuse proliferative lupus nephritis
9. Comparison of high‐dose intravenous methylprednisolone with low‐dose oral prednisolone in acute renal allograft rejection in children
10. Improved oulcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes
11. Intravenous methylprednisolone in minimal change nephrotic syndrome
12. Rifampicin‐induced non‐responsiveness to corticosteroid treatment in nephrotic syndrome
13. The treatment of severe glomerulopathies in children using high dose intravenous methylprednisolone pulses